Citius Oncology, Inc. CTOR Ratios & Valuation
| FY'25 | FY'24 | FY'23 | ||
|---|---|---|---|---|
| Returns | ||||
| Return on equity | -54.4%+4.6pp | -59%-17.9pp | -41.1%— | |
| Liquidity | ||||
| Current ratio | 0.6×+0.2× | 0.3×0.0× | 0.4×— | |
| Per Share | ||||
| Book value per share | $0.61-9.7% | $0.68-82.5% | $3.87-84.0% | |
| Valuation | ||||
| Market capitalization | $60.45M-74.7% | —— | —— | |
| Price / book | 1.8×-5.9× | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Citius Oncology, Inc.'s ratios come from?
- Every ratio is computed from Citius Oncology, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.